Funded Tech Companies

Nuvig Therapeutics

Wondering who provided funding to Nuvig Therapeutics? Leaps by Bayer, Alexandria Venture Investments and Blue Owl Capital invested in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Our mission is to bring innovative and transformational therapies to patients with chronic autoimmune diseases, via induction of mechanisms that restore immune homeostasis. Our first product candidate is a recombinant protein that selectively activates a class of immune regulatory receptors that are naturally involved in rebalancing immune function following inflammation.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/5/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pamela Conley

        

Vice President

Greg Coffey

        

VP - Operations

Heidi Remsberg

        

Company Investors

• Leaps by Bayer
• Alexandria Venture Investments
• Blue Owl Capital (Tim Anderson)
• Bristol-Myers Squibb
• Abrdn
• Platanus Ventures
• Sanofi Ventures (Paulina Hill)
• B Capital Group
• Norwest Venture Partners (Tiba Aynechi)
• Mission BioCapital
• Global BioAccess Fund
• Lotte Ventures
• Digitalis Ventures
• Novo Holdings
• Novo Ventures

Browse more funded tech companies:

NuView Systems | NuVision

Share this article

About Our VC Funding Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary